You searched for Antibody candidate - Page 51 of 69

Best in Biotech 24 Dec 2018

Looking Back on 2018: Our 10 Most Popular Interviews

…The company has a number of candidate drugs in its pipeline targeting various cancers and inflammatory diseases. Its current lead candidate is a monoclonal antibody targeting the antigen CD19. Morphosys…

December 24, 2018 - 8 minutesmins - By Helen Albert

oxford biotherapeutics drug cancer boehringer

News and Trends 18 Apr 2016

UK Drug Discovery sells Cancer Target to German Pharma

…an ongoing collaboration with the Menarini group (Italy) for therapeutic development. Covered by the deal are candidates like OBT357, for acute myeloid leukemia (AML), and OX002, an antibody-drug conjugate targeting…

April 18, 2016 - 2 minutesmins - By Denise Neves Gameiro

Trevor Baglin XO1 SuperX Virtual Biotech

Interview 19 Jun 2017

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

…A patient presented at my hospital with what’s called a paraprotein, which is sort of a rogue antibody produced by the aging immune system. This antibody targeted exosite 1 of…

June 19, 2017 - 7 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 30 Apr 2018

The 5 Best-Selling European Drugs of 2017

…in 2000. Once hailed as a wonder drug, trastuzumab is a monoclonal antibody that recognizes the HER2/neu receptor that is highly expressed in about 20% of breast and gastric cancers….

April 30, 2018 - 7 minutesmins - By Karen O’Hanlon Cohrt

In Depth 11 Dec 2024

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

…Valora’s immunotherapies look much like a conventional antibody, but with one of the usual Y-like arms replaced with a lectin domain. While the antibody domain provides precise targeting to specific…

December 11, 2024 - 9 minutesmins - By Willow Shah-Neville

News and Trends 3 Dec 2015

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

…at the same time and increase drastically the neutralizing capacity of these antibodies compared to monoclonal antibodies. The kinoids induce a natural antibody response against the targeted protein Fighting lupus…

December 3, 2015 - 4 minutesmins - By Joachim Eeckhout

medical cancer checkpoint inhibitor immunotherapy

News and Trends 29 Apr 2021

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

…inhibitors against cancer. Last month, the antibody drug relatlimab, developed by Bristol Myers Squibb, increased the progression-free survival of melanoma patients in phase III. These promising results did more than…

April 29, 2021 - 5 minutesmins - By Mark Zipkin

Infographics 19 Jan 2017

Infographic: A History of Approved Therapeutic Antibodies

…With the recent advancements in antibody engineering, we can expect to see an improvement of their half-lives, effector functions or incorporation into antibody-drug conjugates. Since the first antibody hits the…

January 19, 2017 - 1 minutemin - By Marie Godar

In Depth 19 Jan 2022

Glycans Hit the Sweet Spot in Diagnostics

…the glycosylation patterns of antibodies reveals much more insights into disease progression than just looking at antibody levels. For instance, while the levels of a type of antibody known as…

January 19, 2022 - 5 minutesmins - By Sachin Rawat

genentech immunocore immunotherapy pipette

News and Trends 20 Nov 2018

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

…a fusion protein that combines engineered T cell proteins with antibody fragments. One end of the fusion protein binds with specific antigens on the surface of tumor cells, whereas the…

November 20, 2018 - 2 minutesmins - By Jonathan Smith

More News! 3 Jul 2018

NASA Studies How Outer Space Affects the Immune System

NASA is using an antibody assay to investigate the effect of space flight on white blood cells in astronauts on the International Space Station. The assay used by NASA measures…

July 3, 2018 - 2 minutesmins - By Alexander Burik

liver fibrosis alentis switzerland cirrhosis cancer

News and Trends 30 Apr 2019

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments….

April 30, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Looking Back on 2018: Our 10 Most Popular Interviews

UK Drug Discovery sells Cancer Target to German Pharma

Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin

The 5 Best-Selling European Drugs of 2017

Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?

Meet the Company Fighting Autoimmune Diseases with a Novel Immunotherapy

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

Infographic: A History of Approved Therapeutic Antibodies

Glycans Hit the Sweet Spot in Diagnostics

Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy

NASA Studies How Outer Space Affects the Immune System

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!